In 2013, the Danish Health and Medicines Authorities published a National Clinical Guideline on the treatment of age-related cataracts. The guideline provided evidence-based recommendations on the indication for cataract surgery, cataract surgery in patients with age-related macular degeneration, on the use of toric intraocular lenses (IOLs) to correct preoperative corneal astigmatism, the use of intracameral and topical antibiotics to prevent endophthalmitis, choice of anti-inflammatory medication to control postoperative inflammation and prevent cystoid macular oedema, the use of immediate sequential bilateral cataract surgery and on the postoperative check-up of patients. A questionnaire was sent to all members of the Danish Ophthalmological Society before and after publication of the guideline. The responses showed that the guideline had changed practice patterns so that surgeons were more likely to prescribe nonsteroidal anti-inflammatory eye drops and to not prescribe topical antibiotic eye drops after the guideline was published. Other parameters, most notably the use of toric IOLs and use of postoperative examinations were more guided by reimbursement standards than by evidence-based medicine. Thus, evidence-based guidelines do change practice patterns unless they are counteracted by the reimbursement system.
Introduction
In 2013, the Danish Health and Medicines Authorities published an evidencebased guideline on the treatment of age-related cataract in collaboration with the Danish Ophthalmological Society (Sundhedsstyrelsen 2013) . The guideline focuses on seven specific topics and provides evidence-based recommendations based on a systematic review of the available scientific evidence. If randomized trials were available, they were preferred over non-randomized trials in the preparation of the systematic reviews. The guideline was prepared based on the principles of the grading of recommendations assessment, development, and evaluation system (GRADE; Guyatt et al. 2011) . The topics of the guideline were chosen to cover the preoperative assessment and evaluation of patients with age-related cataracts, cataract surgery in patients with ocular comorbidities, the surgical procedures and postoperative follow-up. Below we summarize the main focus areas and recommendations of the guideline. Later, the effect of the guideline on practice patterns among Danish Ophthalmologists is evaluated.
Indication for cataract surgery
How do we decide when to perform cataract surgery in a patient with cataract? Cataract is most often a slowly progressive condition and visual complaints may not always coincide with the degree of visible cataract. In the pre-intraocular lens (IOL) era, cataract surgery was performed to treat blindness but now the indications are much wider (Lundstrom & Stenevi 2016) . Using visual acuity as a limitation for cataract surgery is an efficient way of reducing the number of patients eligible for surgery (Comas et al. 2008) but our main aim was not to influence the number of patients undergoing surgery but to decide preoperatively who is most likely to benefit from surgery. We did not find that visual acuity could be used as the only indicator of which patients were likely to benefit from cataract surgery. The quality of the evidence was low, and there was a lack of scientific evidence. Thus, we advised that visual acuity alone should not be used to decide who should be offered cataract surgery in the Danish publically financed health system (Kessel et al. 2016a) .
The immediate question then arises: if we cannot rely on preoperative visual acuity to distinguish which patients benefit from surgery -how do we decide who to operate? After an evaluation of several prioritizing methods, we found that the Swedish NIKE (Nationell Indikationsmodell for Kataraktextraktion; Lundstrom et al. 2006 ) was the only preoperative evaluation system that has been shown to have some predictive value when it comes to grouping patients into those who are likely to benefit from surgery and those who are not likely to benefit from surgery. The NIKE system is based on a combination of visual acuity and visual complaints, and it was developed to group patients on waiting lists for cataract surgery. We recommend that the NIKE system should be implemented in Denmark and that only patients who fall in three NIKE groups where a benefit from surgery is expected should be referred for surgery (Sundhedsstyrelsen 2014) .
Cataract surgery in patients with age-related macular degeneration Cataract often coexists with other eye diseases. We chose to focus on cataract surgery in patients with age-related macular degeneration (AMD), and we did not find scientific evidence that cataract surgery increases the risk of incident AMD or that it increases the risk of progression of AMD or the risk of exudative AMD, but the level of evidence was low and more studies were needed. We recommend that cataract surgery can be performed in patients if the ophthalmologist judges that the patient's visual function is likely to improve by surgery (Kessel et al. 2015c ).
Correction of corneal astigmatism by toric intraocular lenses or relaxing incisions
Corneal astigmatism 1.5 dioptre or greater is present in around 20% of patients operated for age-related cataracts (Ostri et al. 2015) . Patients are 34 times more likely to need spectacles for distance viewing per dioptre of astigmatism (Wilkins et al. 2009 ). Cataract surgery changes the refractive status of the eye, and by implanting a toric IOL, the astigmatic component of the refractive error can be corrected. Preoperative corneal astigmatism may, however, also be corrected by changing the corneal curvature by relaxing incisions. We found high quality evidence that toric IOLs provide better uncorrected distance visual outcome, less residual astigmatism and reduces the need for distance spectacles compared to relaxing incisions. The differences were, however, small: 0.37 dioptre for residual astigmatism and the 0.07 logMAR for visual acuity (Kessel et al. 2016b ). The majority of randomized patients had a preoperative corneal astigmatism of three dioptres or less and greater effects may be expected in patients who have even larger amounts of astigmatism. We advise that patients receive a toric IOL if they have a preoperative, regular corneal astigmatism of 2.0 dioptres or greater (Sundhedsstyrelsen 2014).
Antibiotic prevention of postcataract endophthalmitis
We found high quality, overwhelming evidence that intracameral antibiotics effectively prevent postoperative endophthalmitis. This was shown in 2007 in the randomized ESCRS trial (ESCRS Endophthalmitis Study Group 2007), and since then, the results have been replicated in several non-randomized studies (Wejde et al. 2005; ESCRS Endophthalmitis Study Group 2007; Lundstrom et al. 2007; Yu-Wai-Man et al. 2008; Garat et al. 2009; Anijeet et al. 2010; Barreau et al. 2012; van der Merwe et al. 2012; Rosen 2012; Tatham & Brookes 2012; Friling et al. 2013; Matsuura et al. 2013; Myneni et al. 2013; Rodriguez-Caravaca et al. 2013; Shorstein et al. 2013; Beselga et al. 2014; Galvis et al. 2014; Rudnisky et al. 2014) . We have evidence based on more than 1 million cataract surgeries showing that the risk of endophthalmitis is reduced from one in every 485 surgeries when no intracameral antibiotics is used to one of 2855 surgeries when intracameral antibiotics are used. We did not find evidence to suggest that topical antibiotics prevent postoperative endophthalmitis. We recommend that intracameral antibiotics should be used and that topical antibiotics can be avoided (Kessel et al. 2015d ).
Prevention of postsurgical inflammation and pseudophakic macular oedema
Pseudophakic macular oedema is a frequent cause of poor visual acuity after cataract surgery, and it is related to the surgically induced inflammatory response. We compared the risk of postsurgical inflammation and macular oedema in patients receiving nonsteroidal anti-inflammatory (NSAID) topical eye drops versus steroidal antiinflammatory eye drops. We found that the prevalence of pseudophakic macular oedema visible on fluorescein angiography or optical coherence tomography was 25.3% in the groups receiving steroids alone, and it was 3.8% in the groups receiving NSAIDs alone irrespective of the potency of the steroid used. The difference was statistically significant, and the quality of the evidence was high. The NSAIDs were also more efficient than steroids in preventing postsurgical inflammation, but this difference was driven by the less potent steroids and the quality of the evidence was low to moderate. Thus, we recommend that patients receive topical NSAID eye drops after cataract surgery to prevent pseudophakic macular oedema (Kessel et al. 2014) .
Immediate sequential or delayed sequential bilateral cataract surgery Many patients have cataracts on both eyes and may need bilateral surgery. If both eyes are operated on the same date, the number of visits can be reduced saving time and money (Leivo et al. 2011 ). However, operating both eyes at the same date (immediate sequential bilateral surgery) may introduce the risk of bilateral serious periand postoperative complications, and immediate sequential surgery is discouraged by some (Henderson & Schneider 2012; Tan et al. 2012) . We evaluated the literature and did not find any evidence that the risks associated with immediate sequential bilateral surgery are increased compared to delayed sequential bilateral surgery, but the level of evidence was very low and we are not able to provide an evidence-based recommendation (Kessel et al. 2015a ). Thus, if immediate sequential bilateral surgery is performed, it should be performed according to the strict hygienic precautions described by the International Society of Bilateral Cataract Surgeons (Arshinoff et al. 2015) , intracameral antibiotics should be used and the patient should be well informed on the risks and benefits of immediate sequential bilateral cataract surgery.
Postoperative follow-up
Many institutions/surgeons offer a postoperative examination of the patient to assure the patient and healthcare system/surgeon that the surgery went well. In the great majority of patients, cataract surgery is uneventful and the patient is not expected to encounter any serious/visually threatening complications. The question is as follows: what is the value of postoperative examinations? We evaluated whether deferring the first day/early postoperative review would adversely affect patient safety and surgical outcome by looking at the number of detected postoperative complications, visual acuity and the need for unscheduled appointments. All randomized patients received an examination 2 weeks after surgery. The number of detected complications was lower if patients were not seen early after surgery because transient pressure spikes were not detected. There was no difference in the need for unscheduled appointments or the visual outcome. Quality of the evidence ranged from medium to high but too few patients were included to give any indication of the rare but serious postoperative complications such as endophthalmitis. We recommend that routine early postoperative control can be omitted in non-glaucomatous patients after uneventful surgery if symptomatic patients are seen by an ophthalmologist as needed (Kessel et al. 2015b) .
The guideline and above-mentioned recommendations were published in 2013 and have since been presented at meetings arranged by the Danish Ophthalmological Society (Dansk Oftalmologisk Selskab) and the Organization of Danish Ophthalmologists (Danske Øjenlaegers Organization) as well as at meetings sponsored by the pharmaceutical industry locally in most parts of Denmark. A guideline is, however, only useful if it is known by those it is intended for and if practice patterns are changed when it is relevant. The aim of this study was to examine whether the publication of the guideline had an effect on the practice patterns in Denmark.
Patients and Methods
A questionnaire was mailed/e-mailed to all members of the Danish Ophthalmological Society before (in 2013) and after (in 2015) the publication of the national guideline on the treatment of age-related cataracts. The questionnaire was on both occasions sent/emailed twice but non-responders did not receive a personalized reminder or telephone call. The questionnaire contained six items: annual number of surgeries performed, prophylaxis of endophthalmitis (use of intracameral antibiotics, use of topical antibiotics, cleaning of the conjunctiva), postoperative controls [timing and method (physical examination or telephone interview)], use of toric intraocular lenses (IOLs), if patients are offered immediate sequential bilateral cataract surgery in case of bilateral cataract, postoperative eye drops (antiinflammatory + prevention of cystoid macular oedema). In addition, the last questionnaire also contained questions concerning the knowledge and implementation of the national guideline.
Results
A total of 35 030 surgeries were reported in 2013 with 20 715 from hospitals and 14 315 from ophthalmologists working in private practice. In 2015, the total number of reported surgeries was 31 990 with 25 900 from hospitals and 6090 from ophthalmologists in private practice (Fig. 1) . These numbers reflect that surgeries were moved from private practice to hospitals in the capital region of Denmark after a political decision by the local government. The capital region covers approximately 1/3 of the population of Denmark. As there are no official records of the numbers of cataract surgeries performed in Denmark, the coverage of the reported surgeries is unknown.
The majority of hospitals used toric IOLs for the correction of preoperative corneal astigmatism, only 0% and 11% of hospitals never used toric IOLs in 2013 and 2015, respectively. In private practice, 60% never used toric IOLs both in 2013 and in 2015. One-third of hospitals used toric IOLs in the majority (75% or greater) of cases with preoperative astigmatism both in 2013 and in 2015. For private practice, the numbers were 0% in 2015 and 9% in 2013. The main reason given for not implanting toric IOLs was lack of reimbursement of the extra cost associated with toric IOL implantation. Both in 2013 and in 2015, all surgeons (in both hospitals and private practice) used intracameral cefuroxime at the conclusion of surgery. Postoperative topical antibiotics were used by 89% of hospitals in 2013 and 56% in 2015. In private practice, 90% used postoperative topical antibiotics in 2013 and 40% in 2015. Tobramycin was the most commonly used topical antibiotic (Fig. 2) .
Postoperative anti-inflammatory med ication was prescribed by all respondents (Fig. 3) . In 2013, the majority of respondents prescribed dexamethasone, either alone (78% of hospitals, 75% in private practice) or in combination with a non-steroidal anti-inflammatory drug (NSAID, 11% of hospitals and 0% in private practice). In 2015, the preferred anti-inflammatory medication had changed to NSAID, either alone (33% of hospitals and 47% in private practice) or in combination with dexamethasone (55% in hospitals and 40% of private practice).
Immediate sequential bilateral cataract surgery was seldom used both in 2013 and in 2015. In hospitals, immediate sequential bilateral cataract surgery was used for patients who had cataract surgery in general anaesthesia, and in private practice, immediate sequential bilateral cataract surgery was used for the few patients who demanded it or who had cataract surgery for refractive reasons.
In 2013, 75% of hospitals saw patients on the first postoperative day, and in 2015, the number was 78%. In private practice, 86% of patients received a postoperative review on the first day after cataract surgery and 7% were contacted by telephone on the first postoperative day in 2015, the same numbers were 71% and 10% in 2013, respectively. At both time-points, all patients received a postoperative review on the first day in cases of perioperative complications or if postoperative complications could be expected.
Discussion
An evidence-based guideline on the treatment of age-related cataract was published in 2013 (Sundhedsstyrelsen 2013) , and a questionnaire was mailed to all members of the Danish Ophthalmological Society to evaluate whether the guideline had had an impact on clinical practice patterns. Responses covering more than 30 000 cataract surgeries were received. The number of cataract surgeries performed annually is unknown, but based on the size of the population, it is estimated that the responses cover at least half of all cataract surgeries performed in Denmark. Responses showed that practice pattern did indeed change after publication of the guideline.
Indication for cataract surgery was not included as an item in the questionnaire as this was already covered in the guideline for cataract surgery that was published by the Danish Ophthalmological Society in 2001 and which stated that cataract surgery should only be performed in patients with a visual acuity better than 20/40 if there was a very good reason that was well-documented in the medical file (Baun et al. 2001 ). In addition, it was difficult to formulate a question that could specify the exact level of indication for surgery as many ophthalmologists base their indication on a number of parameters including visual acuity, subjective complaints and degree of visible cataract and the relative contribution of these parameters may change between patients. The total numbers of cataract surgeries performed annually in Denmark are unknown but the number of registered surgeries has increased by 55% over a 10-year period and exceeds 50 000 (Sundhedsstyrelsen 2014) . Patients are operated at better preoperative visual acuities ). This change in combination with the demographic changes is expected to challenge the healthcare system (Tuulonen et al. 2009; Kessel 2011) . In Copenhagen, 30% of patients referred from private practice to cataract surgery at a university clinic did not proceed to have surgery (Kessel et al. 2016c ). We recommended that the NIKE system should be implemented and we hoped that this will mean that a greater proportion of those referred proceed to surgery so that the use of preoperative assessment resources is optimized. Cataract surgery in patients with AMD was also not covered as an item in the questionnaire because it was too difficult to formulate questions that would give a reliable indication on which criteria would lead to cataract surgery for the same reasons as stated above. After publication of the guideline, a large retrospective study with prolonged follow-up demonstrated that cataract surgery in patients with exudative AMD is visually beneficial and does not increase the need for anti-VEGF injections (Kessel et al. 2016d ). This finding supports the results of our meta-analysis of epidemiologic studies which showed that the risk of incident AMD or progression of AMD was approximately the same in patients with un-operated cataract and operated cataracts (Kessel et al. 2015c) , suggesting that it is not cataract surgery in itself that is the risk factor but rather common risk factors for cataract and AMD, for example smoking (Kelly et al. 2005; Cong et al. 2008) . Age is the most obvious risk factor, but the effect of age was already corrected for in the estimates of risk of AMD in patients with cataract or pseudophakia in the meta-analysis and can therefore be disregarded in this context. Significant preoperative astigmatism is present in approximately 1/5 of patients (Ostri et al. 2015) . Our systematic review showed that implantation of toric IOLs leads to better results than the use of relaxing incisions (Kessel et al. 2016b ). In addition, toric IOLs are cost-effective (Laurendeau et al. 2009 ). Publication of the guideline did not change the clinical practice patterns because toric IOL implantation was not reimbursed in all parts of the countries. In Denmark, the cost of cataract surgery is covered by the tax-financed healthcare system, whereas the cost of glasses is covered by patients or by the social services for some retirees.
The questionnaire covered the use of intracameral antibiotics. At both timepoints (i.e. before and after publication of the guideline), all respondents used intracameral cefuroxime. In Europe, the results of the ESCRS study have been widely acknowledged and intracameral antibiotics are used frequently (Behndig et al. 2013 (Behndig et al. , 2015 . This is reflected in the low prevalence of endophthalmitis in Europe (Kessel et al. 2015d) . In Europe, an approved formulation of intracameral cefuroxime is available which ease the implementation of the procedure. In other parts of the world, most notably the United States, the use of intracameral antibiotics is still controversial (Schwartz et al. 2016 ) but studies have shown that intracameral antibiotics also prevent endophthalmitis in the United States (Shorstein et al. 2013 ) and that it is more effective than topical antibiotics in preventing endophthalmitis even in an American setting (Herrinton et al. 2016) . This means that opinions are changing (Javitt 2016) , and it is hoped that regulatory bodies such as the FDA will push forward to accept intracameral antibiotics as a safe measure for preventing endophthalmitis as lack of an approved formulation remains an important barrier for the implementation of intracameral antibiotics in many countries outside Europe.
Topical antibiotics were used nearly universally in Denmark in 2013 but this had changed in 2015 after the guideline stated that there is no evidence to suggest that topical antibiotics prevent endophthalmitis and that their use may be associated with the risk of bacterial drug resistance (Sundhedsstyrelsen 2013) . In 2015, 44% of hospitals and 60% of respondents from private practice stated that they no longer used topical antibiotics. It may seem strange that hospitals were more reluctant to adhere to a national guideline than surgeons working in private practice. In fact, a few hospitals had stopped prescribing topical antibiotics postoperatively but encountered endophthalmitis cases after patient selfcontamination from the postoperative anti-inflammatory eye drop bottles by faecal bacterial strains that were neither sensitive to cefuroxime (intracameral) nor tobramycin (the topical antibiotic used prior to the change). Although the change in use of antibiotics in no logical way was associated with the encountered endophthalmitis cases, doctors are conservative and tend to stick to old practice patterns they are comfortable with when something goes wrong.
All respondents prescribed postoperative anti-inflammatory eye drops but the choice of drug changed after the guideline showed that the risk of subclinical pseudophakic macular oedema was reduced from 25% in patients receiving steroids to 4% in patients receiving non-steroidal anti-inflammatory drops (NSAID; Kessel et al. 2014) . In 2013, 89% of hospitals and 75% of respondents from private practice used steroids alone or in combination with NSAIDs. In 2015, this had changed to 88% in hospitals and 87% of respondents from private practice who prescribed NSAIDS either alone or in combination with a steroid. After the publication of our meta-analysis (Kessel et al. 2014) , the American Academy of Ophthalmology (AAO) published a Technology Assessment Report stating that NSAIDs are effective in reducing CME and may increase the speed of visual recovery compared to steroids but that the long-term visual outcome is not documented to be better with NSAID therapy (Kim et al. 2015) . The report did not end by recommending one type of anti-inflammatory therapy over another but advocated that welldesigned trials should be conducted to test the long-term visual outcomes of the two types of therapies and also that a definition of clinical significant pseudophakic macular oedema (CSPME) is needed. While we agree with these statements, the number of patients required to test whether the two treatment groups will differ in prevalence of CSPME will be 6000 patients in each treatment arm if we assume that 1% of patients with subclinical macular oedema will proceed to clinical significant macular oedema. As subclinical CSPME is often a self-limiting condition, the frequency of patients proceeding to visually significant macular oedema is probably even less than 1%, and consequently, the number of included patients should be even higher and such a study even more unrealistic to be performed. The ESCRS sponsored PREMED trial (ClinicalTrial.gov identifier NCT01774474) compares bromfenac to dexamethasone and not to prednisolone acetate which the AAO stated to have better potential for intraocular anti-inflammatory because of better penetration (Kim et al. 2015) . The PREMED trial has macular thickness as primary outcome and clinically significant oedema (with no definition on ClinicalTrial.gov) as secondary outcome with visual acuity ranking as other outcomes. In other words, although the results of the PREMED trial are awaited with great expectations, it will not be able to answer the issues raised by the AAO. What we know at present is that compared to steroids, NSAIDs reduce the frequency of subclinical pseudophakic oedema, inflammation is better controlled, intraocular pressure is lower but visual acuity at 6-8 weeks after surgery is the same in the two groups (Kessel et al. 2014) .
Immediate sequential bilateral cataract surgery (ISBCS) is commonly performed in some countries such as Sweden, Finland and the Canary Islands (Romero-Aroca et al. 2012) . In Denmark, ISBCS is rarely performed and usually only on patients undergoing cataract surgery in general anaesthesia or after specific demands from the patient. The use of ISBCS did not change after publication of the guideline. We were not able to provide an evidence-based recommendation on the use of ISBCS because of a lack of high quality evidence (Kessel et al. 2015a) . Another systematic review found that both ISBCS and delayed bilateral cataract surgery significantly improves quality of life and visual acuity but that ISBCS may deliver additional individual and societal benefits (MalvankarMehta et al. 2015) . In the end, ISBCS requires careful consideration and information of the patient and adherence to strict hygienic rules.
Most patients received a postoperative examination on the first postoperative day, both in hospitals and in private practice and both before and after publication of the guideline. In our systematic review, we did not find that examining the patients on the first postoperative day provided any extra safety to patients compared to an examination at 2 weeks after the surgery and we did not find that an early check-up of patients reduced the need for unscheduled postoperative examinations (Kessel et al. 2015b ). We concluded that patients did not need a standard examination on the first postoperative day if surgery was uncomplicated, and if postoperative pressure spikes were not thought to be detrimental to the patient's visual fields or unless the surgeon was still in training. However, one of the aims of the public hospitals in Denmark is to teach and train surgeons and postoperative examinations are part of the agreement between surgeons working in private practice and the healthcare system reimbursing the private surgeons. This is probably the reasons why we saw little changes in the way postoperative reviews were performed before and after publications of the guideline.
Conclusions
The National Clinical Danish Guideline for Treatment of Age-related Cataracts published in 2013 by the Danish Health and Medicines Authorities in collaboration with the Danish Ophthalmological Society changed practice patterns on important parameters, most notably on the use of postoperative anti-inflammatory medication and postoperative topical antibiotics. On other parameters, most notably the use of toric IOLs, the guideline did not change practice patterns because practice patterns were governed by reimbursement issues and not best standard of care.
